Apollo Hospitals Q2 Revenue Grows 23%, Profit Surges

reported a strong Q2 FY27 performance, reflecting continued demand for healthcare services and complex medical procedures. According to CNBC-TV18, the company’s revenue increased 23% year-on-year, while profit jumped more than 33%, with the headline reporting profit of around ₹660 crore. Reuters reported consolidated net profit of ₹630 crore for the quarter ended September 30, 2026, compared with ₹477 crore in the corresponding period last year, marking approximately 32% growth. The profit performance was broadly in line with analyst expectations, supported by strong demand in the core hospital business. The company’s growth reflects the broader opportunity in India’s healthcare sector, where increasing demand for specialised treatments, rising healthcare awareness and capacity expansion are important long-term drivers. Apollo’s hospital network and focus on complex care provide avenues for operational growth. However, investors should evaluate the performance across its key business segments, including healthcare services, diagnostics, retail pharmacy and digital health. Margin sustainability, occupancy levels, average revenue per patient, new hospital ramp-up and capital expenditure will remain important factors to monitor. Learning Takeaway: Healthcare companies should be assessed not only on revenue and profit growth, but also on patient volumes, case mix, occupancy, operating margins and the efficiency of new hospital capacity. These factors help determine whether earnings growth can remain sustainable over time. Disclosure: This post is for educational purposes only and does not constitute investment advice. Any holdings or conflicts of interest should be disclosed separately.